- Home
- MYFW vs TLSA Comparison
MYFW vs TLSA Comparison
Compare MYFW & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- TLSA
- Stock Information
- Founded
- MYFW 2002
- TLSA 2013
- Country
- MYFW United States
- TLSA United Kingdom
- Employees
- MYFW N/A
- TLSA N/A
- Industry
- MYFW Major Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- TLSA Health Care
- Exchange
- MYFW Nasdaq
- TLSA Nasdaq
- Market Cap
- MYFW 201.1M
- TLSA 187.0M
- IPO Year
- MYFW 2018
- TLSA 2000
- Fundamental
- Price
- MYFW $22.59
- TLSA $1.68
- Analyst Decision
- MYFW Buy
- TLSA
- Analyst Count
- MYFW 2
- TLSA 0
- Target Price
- MYFW $24.25
- TLSA N/A
- AVG Volume (30 Days)
- MYFW 23.5K
- TLSA 342.3K
- Earning Date
- MYFW 10-23-2025
- TLSA 05-06-2025
- Dividend Yield
- MYFW N/A
- TLSA N/A
- EPS Growth
- MYFW 226.95
- TLSA N/A
- EPS
- MYFW 1.18
- TLSA N/A
- Revenue
- MYFW $93,514,000.00
- TLSA N/A
- Revenue This Year
- MYFW $14.41
- TLSA N/A
- Revenue Next Year
- MYFW $12.25
- TLSA N/A
- P/E Ratio
- MYFW $19.68
- TLSA N/A
- Revenue Growth
- MYFW 16.68
- TLSA N/A
- 52 Week Low
- MYFW $17.10
- TLSA $0.63
- 52 Week High
- MYFW $24.88
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- MYFW 51.53
- TLSA 43.68
- Support Level
- MYFW N/A
- TLSA $1.63
- Resistance Level
- MYFW $23.74
- TLSA $1.88
- Average True Range (ATR)
- MYFW 0.56
- TLSA 0.16
- MACD
- MYFW -0.85
- TLSA -0.01
- Stochastic Oscillator
- MYFW 95.16
- TLSA 33.67
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.